Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
Jonathan Weiss, Martin L. Sos*, Danila Seidel, Martin Peifer, Thomas Zander, Johannes M. Heuckmann, Roland T. Ullrich, Roopika Menon, Sebastian Maier, Alex Soltermann, Holger Moch, Patrick Wagener, Florian Fischer, Stefanie Heynck, Mirjam Koker, Jakob Schoettle, Frauke Leenders, Franziska Gabler, Ines Dabow, Silvia QueringsLukas C. Heukamp, Hyatt Balke-Want, Sascha Ansen, Daniel Rauh, Ingelore Baessmann, Janine Altmueller, Zoe Wainer, Matthew Conron, Gavin Wright, Prudence Russell, Ben Solomon, Elisabeth Brambilla, Christian Brambilla, Philippe Lorimier, Steinar Sollberg, Odd Terje Brustugun, Walburga Engel-Riedel, Corinna Ludwig, Iver Petersen, Joerg Saenger, Joachim Clement, Harry Groen, Wim Timens, Hannie Sietsma, Erik Thunnissen, Egbert Smit, Danielle Heideman, Federico Cappuzzo, Claudia Ligorio, Stefania Damiani, Michael Hallek, Rameen Beroukhim, William Pao, Bert Klebl, Matthias Baumann, Reinhard Buettner, Karen Ernestus, Erich Stoelben, Juergen Wolf, Peter Nuernberg, Sven Perner, Roman K. Thomas
Research output: Contribution to journal › Article › Academic › peer-review
740Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer'. Together they form a unique fingerprint.